A bestatin-based fl uorescent probe for aminopeptidase N cell imaging

注册 English

A bestatin-based fl uorescent probe for aminopeptidase N cell imaging

Hui Chen , Hui Wang , Xiao-Jun Qin , Chen Chen , Lu Feng , Lai-Zhong Chen , Lu-Pei Du , Min-Yong Li

Citation: Hui Chen, Hui Wang, Xiao-Jun Qin, Chen Chen, Lu Feng, Lai-Zhong Chen, Lu-Pei Du, Min-Yong Li. A bestatin-based fl uorescent probe for aminopeptidase N cell imaging[J]. Chinese Chemical Letters, 2015, 26(5): 513-516. doi: 10.1016/j.cclet.2015.01.023 shu

shu

A bestatin-based fl uorescent probe for aminopeptidase N cell imaging

通讯作者: Min-Yong Li,

基金项目:
The present work was supported by the Program for New Century Excellent Talents in University (No. NCET-11-0306) (No. NCET-11-0306)

ong Natural Science Foundation (No. JQ201019) (No. JQ201019)

ong University, IIFSDU (No. 2014JC008) (No. 2014JC008)

ong University, GIIFSDU (No. yzc12096). (No. yzc12096)

摘要: Aminopeptidase N (APN) is an important drug target and biomarker for various tumors. The current work characterizes a novel APN-targeted fluorescent probe (Bes-Green, 2) that manifests comparable inhibitory activity with Bestatin. This probe has capacity of tightly binding to the APN for imaging endogenous APN in living human ovarian clear cell carcinoma cells (ES-2) and has potential application in biological study of cellular APN.

关键词:

English

A bestatin-based fl uorescent probe for aminopeptidase N cell imaging

1.
a Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (MOE), School of Pharmacy, Shandong University, Jinan 250012, China;
b China Pharmaceutical University Pharmaceutical Co.
b China Pharmaceutical University Pharmaceutical Co. Ltd., Nanjing 210009, China

Corresponding author: Min-Yong Li,

Received Date: 14 November 2014
Available Online: 28 January 2015
Fund Project:

Abstract: Aminopeptidase N (APN) is an important drug target and biomarker for various tumors. The current work characterizes a novel APN-targeted fluorescent probe (Bes-Green, 2) that manifests comparable inhibitory activity with Bestatin. This probe has capacity of tightly binding to the APN for imaging endogenous APN in living human ovarian clear cell carcinoma cells (ES-2) and has potential application in biological study of cellular APN.

Key words:

1. [1] L.Z. Chen, W. Sun, J. Li, et al., The first ratiometric fluorescent probes for aminopeptidaseN cell imaging, Org. Biomol. Chem. 11 (2013) 378-382.[1] L.Z. Chen, W. Sun, J. Li, et al., The first ratiometric fluorescent probes for aminopeptidaseN cell imaging, Org. Biomol. Chem. 11 (2013) 378-382.
2. [2] J. Dixon, L. Kaklamanis, H. Turley, et al., Expression of aminopeptidase-n (CD 13) innormal tissues and malignant neoplasms of epithelial and lymphoid origin, J. Clin.Pathol. 47 (1994) 43-47.[2] J. Dixon, L. Kaklamanis, H. Turley, et al., Expression of aminopeptidase-n (CD 13) innormal tissues and malignant neoplasms of epithelial and lymphoid origin, J. Clin.Pathol. 47 (1994) 43-47.
3. [3] A.T. Look, R.A. Ashmun, L.H. Shapiro, S.C. Peiper, Human myeloid plasma membraneglycoprotein CD13 (gp150) is identical to aminopeptidase N, J. Clin. Invest.83 (1989) 1299-1307.[3] A.T. Look, R.A. Ashmun, L.H. Shapiro, S.C. Peiper, Human myeloid plasma membraneglycoprotein CD13 (gp150) is identical to aminopeptidase N, J. Clin. Invest.83 (1989) 1299-1307.
4. [4] X.P. Zhang, W.F. Xu, Aminopeptidase N (APN/CD13) as a target for anti-canceragent design, Curr. Med. Chem. 15 (2008) 2850-2865.[4] X.P. Zhang, W.F. Xu, Aminopeptidase N (APN/CD13) as a target for anti-canceragent design, Curr. Med. Chem. 15 (2008) 2850-2865.
5. [5] I. Saiki, J. Yoneda, I. Azuma, et al., Role of aminopeptidase N (CD13) in tumor-cellinvasion and extracellular matrix degradation, Int. J. Cancer 54 (1993) 137-143.[5] I. Saiki, J. Yoneda, I. Azuma, et al., Role of aminopeptidase N (CD13) in tumor-cellinvasion and extracellular matrix degradation, Int. J. Cancer 54 (1993) 137-143.
6. [6] H. Tsukamoto, K. Shibata, H. Kajiyama, et al., Aminopeptidase N (APN)/CD13inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer,BMC Cancer 8 (2008) 74.[6] H. Tsukamoto, K. Shibata, H. Kajiyama, et al., Aminopeptidase N (APN)/CD13inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer,BMC Cancer 8 (2008) 74.
7. [7] R. Pasqualini, E. Koivunen, R. Kain, et al., Aminopeptidase N is a receptor fortumor-homing peptides and a target for inhibiting angiogenesis, Cancer Res. 60(2000) 722-727.[7] R. Pasqualini, E. Koivunen, R. Kain, et al., Aminopeptidase N is a receptor fortumor-homing peptides and a target for inhibiting angiogenesis, Cancer Res. 60(2000) 722-727.
8. [8] F. Curnis, A. Sacchi, L. Borgna, et al., Enhancement of tumor necrosis factor alphaantitumor immunotherapeutic properties by targeted delivery to aminopeptidaseN (CD13), Nat. Biotechnol. 18 (2000) 1185-1190.[8] F. Curnis, A. Sacchi, L. Borgna, et al., Enhancement of tumor necrosis factor alphaantitumor immunotherapeutic properties by targeted delivery to aminopeptidaseN (CD13), Nat. Biotechnol. 18 (2000) 1185-1190.
9. [9] A.H. Negussie, J.L. Miller, G. Reddy, et al., Synthesis and in vitro evaluation of cyclicNGR peptide targeted thermally sensitive liposome, J. Control. Release 143 (2010)265-273.[9] A.H. Negussie, J.L. Miller, G. Reddy, et al., Synthesis and in vitro evaluation of cyclicNGR peptide targeted thermally sensitive liposome, J. Control. Release 143 (2010)265-273.
10. [10] L.A. Plesniak, B. Salzameda, H. Hinderberger, et al., Structure and activity ofCPNGRC: a modified CD13/APN peptidic homing motif, Chem. Biol. Drug Des.75 (2010) 551-562.[10] L.A. Plesniak, B. Salzameda, H. Hinderberger, et al., Structure and activity ofCPNGRC: a modified CD13/APN peptidic homing motif, Chem. Biol. Drug Des.75 (2010) 551-562.
11. [11] G. Pathuri, A.F. Hedrick, B.C. Disch, et al., Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo,Bioconjug. Chem. 23 (2012) 115-124.[11] G. Pathuri, A.F. Hedrick, B.C. Disch, et al., Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo,Bioconjug. Chem. 23 (2012) 115-124.
12. [12] S. Lee, J. Xie, X. Chen, Peptides and peptide hormones for molecular imaging anddisease diagnosis, Chem. Rev. 110 (2010) 3087-3111.[12] S. Lee, J. Xie, X. Chen, Peptides and peptide hormones for molecular imaging anddisease diagnosis, Chem. Rev. 110 (2010) 3087-3111.
13. [13] H. Kobayashi, M. Ogawa, R. Alford, P.L. Choyke, Y. Urano, New strategies forfluorescent probe design in medical diagnostic imaging, Chem. Rev. 110 (2010)2620-2640.[13] H. Kobayashi, M. Ogawa, R. Alford, P.L. Choyke, Y. Urano, New strategies forfluorescent probe design in medical diagnostic imaging, Chem. Rev. 110 (2010)2620-2640.
14. [14] E. Soini, I. Hemmilä, Fluoroimmunoassay: present status and key problems, Clin.Chem. 25 (1979) 353-361.[14] E. Soini, I. Hemmilä, Fluoroimmunoassay: present status and key problems, Clin.Chem. 25 (1979) 353-361.
15. [15] T.T. Dai, L. Liu, D.L. Tao, et al., Influence of Gd doping on the absolute quantumefficiency and lifetime of EuxGd_1-x(TTA)3phens, Chin. Chem. Lett. 25 (2014)892-896.[15] T.T. Dai, L. Liu, D.L. Tao, et al., Influence of Gd doping on the absolute quantumefficiency and lifetime of EuxGd_1-x(TTA)3phens, Chin. Chem. Lett. 25 (2014)892-896.
16. [16] L.Z. Chen, J.J. Mou, Y.Y. Xu, H. Fang, W.F. Xu, Design, synthesis and activity study ofaminopeptidase N targeted 3-amino-2-hydroxy-4-phenyl-butanoic acid derivatives,Drug Discov. Ther. 5 (2011) 61-65.[16] L.Z. Chen, J.J. Mou, Y.Y. Xu, H. Fang, W.F. Xu, Design, synthesis and activity study ofaminopeptidase N targeted 3-amino-2-hydroxy-4-phenyl-butanoic acid derivatives,Drug Discov. Ther. 5 (2011) 61-65.
17. [17] Y. Ma, Q.Y. Tang, J. Zhu, L.H. Wang, C. Yao, Fluorescent and thermal properties ofsiloxane-polyurethanes based on 1, 8-naphthalimide, Chin. Chem. Lett. 25 (2014)680-686.[17] Y. Ma, Q.Y. Tang, J. Zhu, L.H. Wang, C. Yao, Fluorescent and thermal properties ofsiloxane-polyurethanes based on 1, 8-naphthalimide, Chin. Chem. Lett. 25 (2014)680-686.
18. [18] M.B. Harbut, G. Velmourougane, G. Reiss, R. Chandramohanadas, D.C. Greenbaum,Development of bestatin-based activity-based probes for metallo-aminopeptidases,Bioorg. Med. Chem. Lett. 18 (2008) 5932-5936.[18] M.B. Harbut, G. Velmourougane, G. Reiss, R. Chandramohanadas, D.C. Greenbaum,Development of bestatin-based activity-based probes for metallo-aminopeptidases,Bioorg. Med. Chem. Lett. 18 (2008) 5932-5936.
19. [19] A. von Wallbrunn, J. Waldeck, C. Hö ltke, et al., In vivo optical imaging of CD13/APN-expression in tumor xenografts, J. Biomed. Opt. 13 (2008) 011007.[19] A. von Wallbrunn, J. Waldeck, C. Hö ltke, et al., In vivo optical imaging of CD13/APN-expression in tumor xenografts, J. Biomed. Opt. 13 (2008) 011007.
20. [20] Z. Zhang, H. Harada, K. Tanabe, et al., Aminopeptidase N/CD13 targeting fluorescentprobes: synthesis and application to tumor cell imaging, Peptides 26 (2005)2182-2187.[20] Z. Zhang, H. Harada, K. Tanabe, et al., Aminopeptidase N/CD13 targeting fluorescentprobes: synthesis and application to tumor cell imaging, Peptides 26 (2005)2182-2187.
21. [21] W. Zhang, Z. Ma, L. Du, M. Li, Design strategy for photoinduced electron transferbasedsmall-molecule fluorescent probes of biomacromolecules, Analyst 139(2014) 2641-2649.[21] W. Zhang, Z. Ma, L. Du, M. Li, Design strategy for photoinduced electron transferbasedsmall-molecule fluorescent probes of biomacromolecules, Analyst 139(2014) 2641-2649.
22. [22] L. Chen, W. Sun, W. Li, et al., The first ratiometric fluorescent probe for aminopeptidaseN, Anal. Methods 4 (2012) 2661-2663.[22] L. Chen, W. Sun, W. Li, et al., The first ratiometric fluorescent probe for aminopeptidaseN, Anal. Methods 4 (2012) 2661-2663.
23. [23] A. Hahnenkamp, M. Schafers, C. Bremer, C. Holtke, Design and synthesis of smallmoleculefluorescent photoprobes targeted to aminopeptdase N (APN/CD13) foroptical imaging of angiogenesis, Bioconjug. Chem. 24 (2013) 1027-1038.[23] A. Hahnenkamp, M. Schafers, C. Bremer, C. Holtke, Design and synthesis of smallmoleculefluorescent photoprobes targeted to aminopeptdase N (APN/CD13) foroptical imaging of angiogenesis, Bioconjug. Chem. 24 (2013) 1027-1038.
24. [24] L.Z. Chen, L.P. Du, M.Y. Li, The first inhibitor-based fluorescent imaging probe foraminopeptidase N, Drug Discov. Ther. 7 (2013) 124-125.[24] L.Z. Chen, L.P. Du, M.Y. Li, The first inhibitor-based fluorescent imaging probe foraminopeptidase N, Drug Discov. Ther. 7 (2013) 124-125.
25. [25] H. Umezawa, T. Aoyagi, H. Suda, M. Hamada, T. Takeuchi, Bestatin, an inhibitor ofaminopeptidase B, produced by actinomycetes, J. Antibiot. 29 (1976) 97-99.[25] H. Umezawa, T. Aoyagi, H. Suda, M. Hamada, T. Takeuchi, Bestatin, an inhibitor ofaminopeptidase B, produced by actinomycetes, J. Antibiot. 29 (1976) 97-99.
26. [26] W. Xu, Q. Li, Progress in the development of aminopeptidase N (APN/CD13)inhibitors, Curr. Med. Chem. Anticancer Agents 5 (2005) 281-301.[26] W. Xu, Q. Li, Progress in the development of aminopeptidase N (APN/CD13)inhibitors, Curr. Med. Chem. Anticancer Agents 5 (2005) 281-301.

WeChat

扫一扫看文章

计量

PDF下载量: 0
文章访问数: 848
HTML全文浏览量: 18

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

/

下载: 全尺寸图片幻灯片

分享

用微信扫码二维码

分享至好友和朋友圈